Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Biodesix (BDSX) Leases (2022 - 2026)

Biodesix filings provide 5 years of Leases readings, the most recent being $3.2 million for Q1 2026.

  • On a quarterly basis, Leases rose 62.49% to $3.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $3.2 million, a 62.49% increase, with the full-year FY2025 number at $3.0 million, up 69.61% from a year prior.
  • Leases hit $3.2 million in Q1 2026 for Biodesix, up from $3.0 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $3.5 million in Q3 2022 to a low of $1.2 million in Q1 2022.
  • Median Leases over the past 5 years was $2.1 million (2023), compared with a mean of $2.3 million.
  • The widest YoY moves for Leases: up 82.83% in 2023, down 41.31% in 2023.
  • Biodesix's Leases stood at $3.0 million in 2022, then tumbled by 41.31% to $1.7 million in 2023, then increased by 1.26% to $1.8 million in 2024, then surged by 69.61% to $3.0 million in 2025, then increased by 6.37% to $3.2 million in 2026.
  • The last three reported values for Leases were $3.2 million (Q1 2026), $3.0 million (Q4 2025), and $2.9 million (Q3 2025) per Business Quant data.